{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:21:38Z","timestamp":1765354898914,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tampere Tuberculosis Foundation, Tampere, Finland"},{"name":"The Finnish Cultural Foundation, Pirkanmaa Regional Fund, Finland"},{"name":"Competitive State Research Funding of Tampere University Hospital, Tampere, Finland"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The aim of the present study was to investigate the levels of YKL-40 during and after coronary artery bypass grafting surgery (CABG) and to establish possible connections between YKL-40 and markers of oxidative stress, inflammation, and myocardial injury. Patients undergoing elective CABG utilizing cardiopulmonary bypass (CPB) were recruited into the study. Blood samples were collected at the onset of anesthesia, during surgery and post-operatively. Levels of YKL-40, 8-isoprostane, interleukin-8 (IL-8), monocyte chemotactic protein-1 (MCP-1) and troponin T (TnT) were measured by immunoassay. YKL-40 levels increased significantly 24 h after CPB. Positive correlation was seen between post-operative TnT and YKL-40 levels (r = 0.457, p = 0.016) and, interestingly, baseline YKL-40 predicted post-operative TnT increase (r = 0.374, p = 0.050). There was also a clear association between YKL-40 and the chemotactic factors MCP-1 (r = 0.440, p = 0.028) and IL-8 (r = 0.484, p = 0.011) linking YKL-40 to cardiac inflammation and fibrosis following CABG. The present results show, for the first time, that YKL-40 is associated with myocardial injury and leukocyte-activating factors following coronary artery bypass surgery. YKL-40 may be a factor and\/or biomarker of myocardial inflammation and injury and subsequent fibrosis following heart surgery.<\/jats:p>","DOI":"10.3390\/cells11213378","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T07:17:48Z","timestamp":1666768668000},"page":"3378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammatory Glycoprotein YKL-40 Is Elevated after Coronary Artery Bypass Surgery and Correlates with Leukocyte Chemotaxis and Myocardial Injury, a Pilot Study"],"prefix":"10.3390","volume":"11","author":[{"given":"Antti","family":"Laurikka","sequence":"first","affiliation":[{"name":"The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0017-1291","authenticated-orcid":false,"given":"Katriina","family":"Vuolteenaho","sequence":"additional","affiliation":[{"name":"The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesa","family":"Toikkanen","sequence":"additional","affiliation":[{"name":"Tampere University Hospital Heart Center Co., P.O. Box 2000, 33521 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0733-245X","authenticated-orcid":false,"given":"Timo","family":"Rinne","sequence":"additional","affiliation":[{"name":"Tampere University Hospital Heart Center Co., P.O. Box 2000, 33521 Tampere, Finland"},{"name":"Department of Anaesthesia, Tampere University Hospital, P.O. Box 2000, 33521 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiina","family":"Lepp\u00e4nen","sequence":"additional","affiliation":[{"name":"The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[{"name":"The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Tarkka","sequence":"additional","affiliation":[{"name":"Tampere University Hospital Heart Center Co., P.O. Box 2000, 33521 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-6048","authenticated-orcid":false,"given":"Jari","family":"Laurikka","sequence":"additional","affiliation":[{"name":"Tampere University Hospital Heart Center Co., P.O. Box 2000, 33521 Tampere, Finland"},{"name":"Finnish Cardiovascular Research Center Tampere, Tampere University, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-0316","authenticated-orcid":false,"given":"Eeva","family":"Moilanen","sequence":"additional","affiliation":[{"name":"The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University Hospital, Tampere University, 33014 Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","article-title":"Ischaemic conditioning and reperfusion injury","volume":"13","author":"Hausenloy","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Urbanowicz, T.K., Olasi\u0144ska-Wi\u015bniewska, A., Michalak, M., G\u0105secka, A., Rodzki, M., Perek, B., and Jemielity, M. (2021). Cardioprotective effect of low level of LDL cholesterol on perioperative myocardial injury in off-pump coronary artery bypass grafting. Medicina, 57.","DOI":"10.3390\/medicina57090875"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sakamoto, Y., Morimoto, Y., Hanada, M., Yano, Y., Sawai, T., Miura, T., Eishi, K., and Kozu, R. (2021). Determining factors for independent walking in patients undergoing cardiovascular surgery: Differences between coronary artery bypass grafting, heart valve surgery, and aortic surgery. Healthcare, 9.","DOI":"10.3390\/healthcare9111475"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1074\/jbc.270.22.13076","article-title":"Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling","volume":"270","author":"Shackelton","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"25803","DOI":"10.1016\/S0021-9258(19)74461-5","article-title":"Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family","volume":"268","author":"Hakala","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/bj20020075","article-title":"The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways","volume":"365","author":"Recklies","year":"2002","journal-title":"Biochem. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-4827(03)00069-7","article-title":"gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells","volume":"287","author":"Nishikawa","year":"2003","journal-title":"Exp. Cell Res."},{"key":"ref_9","first-page":"215140","article-title":"YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints","volume":"2014","author":"Koskinen","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Vuolteenaho, K., Lepp\u00e4nen, T., Kekkonen, R., Korpela, R., and Moilanen, E. (2014). Running a marathon induces changes in adipokine levels and in markers of cartilage degradation--novel role for resistin. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110481"},{"key":"ref_11","first-page":"399","article-title":"Chitinases and immunity: Ancestral molecules with new functions","volume":"221","author":"Distefano","year":"2015","journal-title":"Immunobiology"},{"key":"ref_12","first-page":"1797512","article-title":"Glycoprotein YKL-40 levels in plasma are associated with fibrotic changes on HRCT in asbestos-exposed subjects","volume":"2017","author":"Vuolteenaho","year":"2017","journal-title":"Mediators Inflamm."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"V\u00e4\u00e4n\u00e4nen, T., Vuolteenaho, K., Kautiainen, H., Nieminen, R., M\u00f6tt\u00f6nen, T., Hannonen, P., Korpela, M., Kauppi, M.J., Laiho, K., and Kaipiainen-Sepp\u00e4nen, O. (2017). Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183294"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/21681805.2017.1327885","article-title":"High YKL-40 is associated with poor survival in patients with renal cell carcinoma: A novel independent prognostic marker","volume":"51","author":"Kallio","year":"2017","journal-title":"Scand. J. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MCA.0b013e3282f40dd5","article-title":"Serum levels of YKL-40 increases in patients with acute myocardial infarction","volume":"19","author":"Nojgaard","year":"2008","journal-title":"Coron. Artery Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e014634","DOI":"10.1161\/JAHA.119.014634","article-title":"Prognosis and reclassification by ykl-40 in stable coronary artery disease","volume":"9","author":"Schroder","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/14017430903402218","article-title":"Plasma YKL-40 levels are elevated in patients with chronic heart failure","volume":"44","author":"Rathcke","year":"2010","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.ATV.19.3.687","article-title":"Strong induction of members of the chitinase family of proteins in atherosclerosis: Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages","volume":"19","author":"Boot","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cardfail.2010.05.029","article-title":"Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure","volume":"16","author":"Bilim","year":"2010","journal-title":"J. Card. Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e14920","DOI":"10.1097\/MD.0000000000014920","article-title":"Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCA.0b013e328241d991","article-title":"Serum YKL-40 levels in patients with coronary artery disease. Coron","volume":"18","author":"Kucur","year":"2007","journal-title":"Artery Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcla.21804","article-title":"Diagnostic value of serum YKL-40 level for coronary artery disease: A meta-analysis","volume":"30","author":"Song","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/joim.12006","article-title":"The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality","volume":"273","author":"Mygind","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_24","first-page":"205","article-title":"Early reversibility of histological changes after experimental acute cardiac volume-overload","volume":"12","author":"Huuskonen","year":"2022","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/ejcts\/ezt634","article-title":"Adipocytokine resistin correlates with oxidative stress and myocardial injury in patients undergoing cardiac surgery","volume":"46","author":"Laurikka","year":"2014","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_26","unstructured":"Hillsdale, N.J. (1988). Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2217\/bmm.14.20","article-title":"Serum YKL-40 for monitoring myocardial ischemia after revascularization in patients with stable coronary artery disease","volume":"8","author":"Harutyunyan","year":"2014","journal-title":"Biomark. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Haider, A., Khwaja, I.A., Khan, A.H., Yousaf, M.S., Zaneb, H., Qureshi, A.B., and Rehman, H. (2021). Efficacy of whole-blood Del Nido cardioplegia compared with diluted Del Nido cardioplegia in coronary artery bypass grafting: A retrospective monocentric analysis of Pakistan. Medicina, 57.","DOI":"10.3390\/medicina57090918"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7018393","DOI":"10.1155\/2017\/7018393","article-title":"Ischemia\/reperfusion injury following acute myocardial infarction: A critical issue for clinicians and forensic pathologists","volume":"2017","author":"Neri","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","article-title":"Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction","volume":"121","author":"Nahrendorf","year":"2010","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MOH.0000000000000389","article-title":"The regulation and importance of monocyte chemoattractant protein-1","volume":"25","author":"Bianconi","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1479-5876-12-188","article-title":"A theoretical timeline for myocardial infarction: Immunohistochemical evaluation and western blot quantification for interleukin-15 and monocyte chemotactic protein-1 as very early markers","volume":"12","author":"Turillazzi","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/eurjhf\/hfs183","article-title":"Heart failure determines the myocardial inflammatory response to injury","volume":"15","author":"Kortekaas","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12265-020-10006-7","article-title":"Chemokines in myocardial infarction","volume":"14","author":"Chen","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.1201827","article-title":"YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-B pathways, causing bronchial smooth muscle proliferation and migration","volume":"190","author":"Tang","year":"2013","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ejcts\/ezt637","article-title":"Oxidative stress during extracorporeal circulation","volume":"46","author":"McDonald","year":"2014","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ito, F., Sono, Y., and Ito, T. (2019). Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: Oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants, 8.","DOI":"10.3390\/antiox8030072"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/bj20040099","article-title":"The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha","volume":"380","author":"Ling","year":"2004","journal-title":"Biochem. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0003-4975(02)03658-5","article-title":"Proinflammatory and antiinflammatory cytokines after cardiac operation: Different cellular sources at different times","volume":"74","author":"Franke","year":"2002","journal-title":"Ann. Thorac. Surg."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/21\/3378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:03:05Z","timestamp":1760144585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/21\/3378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":40,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["cells11213378"],"URL":"https:\/\/doi.org\/10.3390\/cells11213378","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2022,10,26]]}}}